| Cryosite Limited (CTE) ORDINARY FULLY PAID |
Health Care |
$59 |
Trading Update - Financial Year-to-Date - 30 April 2026
|
27 May 2026 8:53AM |
$1.070 |
$1.200 |
risen by
12.15%
|
|
CTE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 22% to $13.8 million.
- EBITDA increased by 28% to $3.4 million.
- Cryosite completed infrastructure expansion at Ferndell Street.
- The Adderley Street warehouse is under commissioning.
- Refinanced debt facility with NAB until 2030.
- Achieved EcoVadis Gold Medal status for sustainability.
- Participated in the R&D Tax Incentive program.
- Operational volumes indicate continuing positive momentum.
- Cryosite focuses on growth in Ultra-Frozen & Cryogenic segment.
- Continues to manage cost pressures effectively.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$95 |
Update - Notification of buy-back - ARA
|
27 May 2026 8:51AM |
$0.480 |
$0.500 |
risen by
4.17%
|
|
| Memphasys Limited (MEM) ORDINARY FULLY PAID |
Health Care |
$25 |
ITL Orders 1000 Felix Cartridges Across MENA Markets
|
27 May 2026 8:51AM |
$0.004 |
$0.008 |
risen by
100%
|
|
MEM - Price-sensitive ASX Announcement
Full Release
Key Points
- ITL orders 1,000 Felix™ cartridges for MENA markets.
- Hamad Medical Corporation orders a second Felix™ console.
- New markets include UAE and Kuwait following initial evaluations.
- Turkey's regulatory approval is pending with orders expected in July.
- Confirmed ITL orders have reached 1,800 cartridges.
- 400 cartridges to be dispatched to Qatar, UAE, and Kuwait immediately.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Guzman Y Gomez Limited (GYG) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,186 |
Update - Notification of buy-back - GYG
|
27 May 2026 8:51AM |
$19.420 |
$21.950 |
risen by
13.03%
|
|
| ANZ Group Holdings Limited (ANZ) ORDINARY FULLY PAID |
Financials |
$111,257 |
Change of Director's Interest Notice
|
27 May 2026 8:50AM |
$35.660 |
$36.890 |
risen by
3.45%
|
|
| Constellation Resources Limited (CR1) ORDINARY FULLY PAID |
Materials |
$10 |
Corporate Presentation - Helium and Methane Exploration
|
27 May 2026 8:50AM |
$0.210 |
$0.120 |
fallen by
42.86%
|
|
| Webjet Group Limited (WJL) ORDINARY FULLY PAID |
Consumer Discretionary |
$159 |
Update - Notification of buy-back - WJL
|
27 May 2026 8:50AM |
$0.455 |
$0.405 |
fallen by
10.99%
|
|
| Redcastle Resources Limited (RC1) ORDINARY FULLY PAID |
Materials |
$15 |
Continuous Mining Operations Underway at Redcastle Reef
|
27 May 2026 8:48AM |
$0.135 |
$0.110 |
fallen by
18.52%
|
|
RC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Continuous mining operations started at Redcastle Reef.
- RC1 transitions from exploration to dual mining and exploration.
- BML Ventures funds initial mining operations.
- Capital-light structure to preserve financial resources.
- Ore stockpiling and haulage to commence in June 2026.
- First toll treatment planned for July 2026.
- Potential cash flow to support further exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$594 |
Update - Notification of buy-back - RG1
|
27 May 2026 8:47AM |
$2.330 |
$2.530 |
risen by
8.58%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$202 |
High Grade Assays Indicate Growth for Tunkillia Area 51
|
27 May 2026 8:47AM |
$0.915 |
$0.745 |
fallen by
18.58%
|
|
BGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 2 upgrade drilling at Tunkillia Gold Project shows promising high-grade assay results.
- Approximately 30,000 meters of reverse circulation drilling planned.
- Assays indicate potential for resource expansion and optimized open pit growth.
- Significant results from the north and south ends of the modeled open pit in Area 51.
- Completion of a Pre-Feasibility Study by the end of 2026 planned.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| VRX Silica Limited (VRX) ORDINARY FULLY PAID |
Materials |
$38 |
Renounceable Rights Issue to Raise up to $6.2 million
|
27 May 2026 8:47AM |
$0.049 |
$0.039 |
fallen by
20.41%
|
|
VRX - Price-sensitive ASX Announcement
Full Release
Key Points
- 1 for 5 renounceable rights issue at 4 cents per share
- Discount of 18.4% to last closing price
- 27.3% discount to 90-day VWAP
- 1 free attaching option per 2 new shares
- Option exercise price of 10 cents, expiring 30 June 2028
- Partially underwritten up to $2 million by Mahe Capital
- Funds for Arrowsmith North, Arramall purchase, Muchea project
- Rights trading begins 1 June 2026
- Offer closes 19 June 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MinRex Resources Limited (MRR) ORDINARY FULLY PAID |
Materials |
$33 |
2026 Growth and Execution Plan
|
27 May 2026 8:47AM |
$0.017 |
$0.016 |
fallen by
8.82%
|
|
MRR - Price-sensitive ASX Announcement
Full Release
Key Points
- Maximizing Tlamino Project value by targeting JORC 2012 resources conversion.
- Advancing statutory permitting pathway for the Tlamino Project.
- Economic revaluation of Tlamino amid increased gold and silver prices.
- Executing a dual-stream strategy for near-term and long-term value creation.
- Fully funded ~7,000m drilling program at Tlamino.
- Maintaining stakeholder engagement and community relationships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$214 |
Mayne Pharma to present at Jefferies Healthcare Conference
|
27 May 2026 8:44AM |
$2.340 |
$2.630 |
risen by
12.39%
|
|
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$617 |
Update - Notification of buy-back - FPR
|
27 May 2026 8:44AM |
$2.800 |
$2.890 |
risen by
3.21%
|
|
| Biome Australia Limited (BIO) ORDINARY FULLY PAID |
Consumer Staple |
$62 |
BMB18 clinical trial expands to dual site
|
27 May 2026 8:43AM |
$0.240 |
$0.270 |
risen by
12.50%
|
|
BIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Multi-centre BMB18 clinical trial across Australia and Greece.
- Inclusion of Harokopio University of Athens as a second site.
- Randomised, double-blind, placebo-controlled study with 240 participants.
- Assessment of two BMB18 dosages over six-week intervention.
- Aims to produce first human clinical evidence for Lactiplantibacillus plantarum strain.
- BMB18 is Biome's first wholly proprietary strain.
- Recruitment commencing within Q4 FY26 timeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EMvision Medical Devices Limited (EMV) ORDINARY FULLY PAID |
Health Care |
$149 |
Aeromedical Study De-Risks Rural & Remote Stroke Use Cases
|
27 May 2026 8:40AM |
$1.710 |
$1.600 |
fallen by
6.43%
|
|
EMV - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful completion of aeromedical feasibility and usability study for First Responder Brain Scanner.
- Study conducted with Royal Flying Doctor Service, Australian Stroke Alliance, and South Australian Ambulance Service.
- First Responder Brain Scanner effectively deployed in real-world aeromedical environments.
- Positive feedback from operators, with scan data quality unaffected by flight conditions.
- Study de-risks device's rural and remote stroke care use cases.
- EMVision received a $400,000 milestone payment under the Australian Stroke Alliance Project Agreement.
- The device is being evaluated in pre-hospital use cases including Mobile Stroke Unit and road ambulance settings.
- Production equivalent units in development for data collection and regulatory clearance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prodigy Gold NL (PRX) ORDINARY FULLY PAID |
Materials |
$24 |
Scoping Study Confirms Development Opportunity for Hyperion
|
27 May 2026 8:39AM |
$0.081 |
$0.070 |
fallen by
13.58%
|
|
PRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Scoping Study confirms development opportunity for Hyperion Gold Deposit.
- Hyperion is located in the Tanami Region, Northern Territory, Australia.
- Study shows geologic and mining feasibility for advanced studies.
- Production target of 4.2 Mt at 1.9 g/t Au for 260Koz of gold.
- Mineral resources categorized as Indicated and Inferred.
- Significant exploration potential as mineralization remains open.
- Four-year contractor mining operation planned.
- Further work needed for prefeasibility level, including geotechnical and environmental studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tabcorp Holdings Limited (TAH) ORDINARY FULLY PAID |
Consumer Discretionary |
$1,972 |
ASX Listing Rule 3.19 notification
|
27 May 2026 8:36AM |
$0.695 |
$0.860 |
risen by
23.74%
|
|
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$178 |
Appointment of Chief Financial Officer
|
27 May 2026 8:35AM |
$0.165 |
$0.170 |
risen by
3.03%
|
|
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$8,452 |
Update - Notification of buy-back - LNW
|
27 May 2026 8:35AM |
$112.100 |
$109.700 |
fallen by
2.14%
|
|
| Atturra Limited (ATA) ORDINARY FULLY PAID |
Information Technology |
$147 |
Update - Notification of buy-back - ATA
|
27 May 2026 8:32AM |
$0.470 |
$0.400 |
fallen by
14.89%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$14 |
Update - Notification of buy-back - 5GN
|
27 May 2026 8:32AM |
$0.080 |
$0.053 |
fallen by
33.75%
|
|
| Muzinich BDC Income Fund - Active ETF (BDCI) MUZINICH BDC INCOME FUND - ACTIVE ETF |
- |
$3 |
Distribution for month ending 31 May 2026
|
27 May 2026 8:31AM |
$19.150 |
$19.590 |
risen by
2.30%
|
|
| Switzer Dividend Growth Fund (Managed Fund) (SWTZ) |
Financials |
$56 |
Distribution for month ending 31 May 2026
|
27 May 2026 8:31AM |
$2.420 |
$2.420 |
fallen by
0%
|
|
| Yugo Metals Limited (YUG) ORDINARY FULLY PAID |
Materials |
$19 |
Gold discovery in first-ever drilling results from Erak
|
27 May 2026 8:31AM |
$0.090 |
$0.046 |
fallen by
48.89%
|
|
YUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Yugo Metals announces gold discovery from first-ever drilling at Erak Prospect.
- Five diamond drillholes completed, intersecting significant mineralised alteration zones.
- Prominent phyllic alteration associated with gold-bearing zones.
- Drillhole ERDD006 showed 34 meters of alteration in the eastern part of Erak.
- Polymetallic mineralisation includes gold, silver, copper, and antimony.
- Key intersection: 8m at 1.2 AuEq g/t, including 4m with specific mineral content.
- Ongoing drilling aims to explore mineralisation extensions.
- Future drilling to target high previous trenching results for gold.
- Results confirm potential for significant growth at the Erak gold system.
- Initial results are promising, with further assays pending.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
